MIM
ALAB icon

MetLife Investment Management’s Astera Labs ALAB Stock Holding History

MetLife Investment Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.11M Buy
8,512
+574
+7% +$152K 0.02% 757
2026
Q1 		$870K Sell
7,938
-198
-2% -$28.2K ﹤0.01% 1464
2025
Q4 		$1.35M Buy
8,136
+70
+0.9% +$11.7K 0.01% 1268
2025
Q3 		$1.58M Sell
8,066
-838
-9% -$138K 0.01% 1219
2025
Q2 		$805K Buy
8,904
+6,681
+301% +$528K ﹤0.01% 1427
2025
Q1 		$133K Buy
2,223
+86
+4% +$7.96K ﹤0.01% 2398
2024
Q4 		$283K Buy
2,137
+1,702
+391% +$160K ﹤0.01% 2113
2024
Q3 		$22.8K Sell
435
-9
-2% -$422 ﹤0.01% 2816
2024
Q2 		$26.9K Buy
+444
New +$30.8K ﹤0.01% 2858

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MetLife Investment Management's ALAB Position: Q2 2026 in Review

MetLife Investment Management increased its Astera Labs (ALAB) stake by 7.2% in Q2 2026, buying an estimated $152K and bringing the position to 8,512 shares worth $4.11M. The position accounts for 0.02% of the portfolio, ranked #757.

MetLife Investment Management first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • MetLife Investment Management held 8,512 shares of Astera Labs worth $4.11M as of Q2 2026.
  • MetLife Investment Management bought 574 Astera Labs shares in Q2 2026, an estimated $152K.
  • Astera Labs made up 0.02% of MetLife Investment Management's portfolio in Q2 2026, its #757 holding.
  • MetLife Investment Management first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.